PEPTIDE DATABASE
Retatrutide
LY3437943
An investigational peptide-based triple receptor agonist targeting GIP, GLP-1 and glucagon receptors, studied primarily in metabolic and obesity-related clinical research.
Triple GIP / GLP-1 / glucagon receptor agonist
Clinical-stage investigational compound
Investigational; regulatory status depends on jurisdiction and indication
COMPOUND DATA
Molecular Information
Classification
Triple GIP / GLP-1 / glucagon receptor agonist
Molecular Weight
Not available
Molecular Formula
Not available
Research Status
Clinical-stage investigational compound
OVERVIEW
About Retatrutide
An investigational peptide-based triple receptor agonist targeting GIP, GLP-1 and glucagon receptors, studied primarily in metabolic and obesity-related clinical research.
STATUS
Regulatory Information
Investigational; regulatory status depends on jurisdiction and indication
Regulatory status can vary by jurisdiction and may change over time.
HAXBIO COMMUNITY
Retatrutide Discussions & News
No community posts yet
Nothing about Retatrutide has been posted yet.
HaxBio provides information for educational and research purposes. Information on this page should not be interpreted as medical advice.